Limba
|
LQZ-7I is a novel selectively inhibitor of survivin dimerizationwith IC50s of 4.8 µM and 3.1 µM in prostate cancer cell lines PC-3 and C4-2, respectively. LQZ-7I orally effectively inhibits xenograft tumor growth and induces survivin loss in tumors.
Price | 1.328,00 RON (preturile sunt fara TVA) |
---|---|
Description |
LQZ-7I is a novel selectively inhibitor of survivin dimerizationwith IC50s of 4.8 µM and 3.1 µM in prostate cancer cell lines PC-3 and C4-2, respectively. LQZ-7I orally effectively inhibits xenograft tumor growth and induces survivin loss in tumors. |